INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,008 | -80.7% | 14,295 | -78.7% | 0.02% | -86.3% |
| Q4 2022 | $2,344,329 | +402.0% | 67,192 | +704.5% | 0.12% | +588.9% |
| Q3 2022 | $467,000 | -87.5% | 8,352 | -88.5% | 0.02% | -88.9% |
| Q2 2022 | $3,747,000 | +15.7% | 72,400 | +62.5% | 0.16% | +16.5% |
| Q1 2022 | $3,238,000 | +155.4% | 44,554 | +315.5% | 0.14% | +73.8% |
| Q4 2021 | $1,268,000 | -19.9% | 10,723 | -9.1% | 0.08% | -29.8% |
| Q3 2021 | $1,583,000 | +438.4% | 11,800 | +118.5% | 0.11% | +128.0% |
| Q4 2020 | $294,000 | – | 5,400 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |